Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Preclinical data for MDL-001 establish proof-of-concept for an oral therapy targeting HCV/HBV co-infection, a population with an over 100x elevated liver cancer risk.